We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
Here’s a scary fact (based on research out of Mass General Brigham): If a woman has early menopause, the later she starts hormone therapy, the greater her risk of developing Alzheimer’s.
Quoth one of the study’s authors:
“We found that the highest levels of tau, a protein involved in Alzheimer’s disease, were only observed in hormone therapy users who reported a long delay between age at menopause onset and their initiation of hormone therapy.”
Said another, a bit more bluntly, “When it comes to hormone therapy, timing is everything.”
A new study out of the Mayo Clinic (with a partner in South Korea) found that low-dose naltrexone seems both to work just great for combating the symptoms of fibromyalgia. It was already used off-label for that purpose, but the authors wanted to add a dose of science — to “systematically assess the current evidence.”
Voila! In looking at the studies out there, they found that LDN helped manage the symptoms of fibromyalgia with “no severe adverse events were reported.”
April means women’s health, and we’re all about that — we’ve got a great new webinar with pharmacist Baylor Rice talking all about the best over-the-counter supplements and nutraceuticals to help deal with women’s health and hormone issues, especially when it comes to menopause. Learn about supplements such as I3C, chasteberry, and DIM and how they could play into your overall hormone health.
Attend live on Wednesday, April 12 (2 to 3 pm EDT) to share your questions and thoughts; there’ll be a Q&A at the end of the webinar.
Or watch it anytime — register (it’s free!) and we’ll send you a link to the recording and slide show right after the webinar ends.
Compounders can help ease the side effects of colorectal cancer treatment
Once upon a time, you may have had to sit down with your young children to discuss the birds and the bees. But these tough conversations do not stop in adolescence: Have you talked to your (adult) children about “the bums and the bees”?
If they are 45 years or older, you should encourage them to start colorectal cancer screening. March marks Colorectal Cancer Awareness month and should serve as a friendly reminder to have those tough conversations.
Colorectal cancer (CRC) is a disease in which cells in the colon or rectum grow out of control.1 It is the 4th most common type of cancer in the United States.2 Anyone can develop it, but some have a higher risk than others—for instance, patients with
